AU Patent

AU2009224329B2 — Pyridylaminoacetic acid compound

Assigned to Ube Corp · Expires 2013-11-07 · 13y expired

What this patent protects

Disclosed is a novel pyridylaminoacetic acid compound represented by general formula (1) [wherein R

USPTO Abstract

Disclosed is a novel pyridylaminoacetic acid compound represented by general formula (1) [wherein R

Drugs covered by this patent

omidenepag-isopropyl (OMIDENEPAG ISOPROPYL)

Patent Metadata

Patent number: AU2009224329B2
Jurisdiction: AU
Classification: —
Expires: 2013-11-07
Drug substance claim: No
Drug product claim: No
Assignee: Ube Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.